Form 4: NeueHealth Director Makhzoumi Reports Transaction in Beneficial Ownership

Director Mohamad Makhzoumi reports a transaction involving NeueHealth, Inc. common stock and restricted stock units, indicating changes in beneficial ownership.

Summary

• Mohamad Makhzoumi, a director of NeueHealth, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On May 13, 2025, Makhzoumi reported the acquisition of 10,500 shares of common stock and the disposal of 16,443 shares.
• These transactions also involved 10,500 restricted stock units, which vested on the same date.
• Makhzoumi's indirect beneficial ownership includes holdings through NEA 15, NEA 15-OF, NEA 16, and NEA 17.
• He disclaims beneficial ownership of the securities held by these entities to the extent he has no pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing is a standard disclosure of insider transactions. The acquisition and disposal of shares don't inherently indicate positive or negative sentiment without further context.

Positives

• The vesting of restricted stock units could be seen as a positive sign, aligning Makhzoumi's interests with the company's performance.

Negatives

• The disposal of 16,443 shares could be interpreted negatively, although the context of the transaction is not fully clear from the filing.

Risks

• The Form 4 filing itself doesn't inherently indicate risks, but changes in insider ownership can sometimes signal shifts in sentiment or strategy.
• The disclaimer of beneficial ownership highlights the complexity of Makhzoumi's relationship with the company through various investment partnerships, which could create potential conflicts of interest.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their transactions in company stock. This filing is specific to NeueHealth and doesn't provide broader industry context.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider transactions, which can influence investor confidence.

Key Dates

Keywords

beneficial ownership, Form 4, NeueHealth, Makhzoumi, restricted stock units, NEA, insider trading